Atlas Trials

Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris

Clinical trial NCT01628549 · COMPLETED

Trial details

NCT number
NCT01628549
Sponsor
Almirall, S.A.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2012-06-30
Primary completion
2012-11-16
Enrollment
285

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.